TrialJAMA neurology2013

High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial.

Richard A Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.